A 3-WAY CROSSOVER STUDY TO COMPARE THE PHARMACOKINETICS AND ACCEPTABILITY OF SULTAMICILLIN AT 2 DOSE LEVELS WITH THAT OF AMPICILLIN

被引：22

作者：

HARTLEY, S

WISE, R

机构：

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 1982年 / 10卷 / 01期

关键词：

D O I：

10.1093/jac/10.1.49

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

收藏

页码：49 / 55

页数：7

相关论文

共 5 条

[1]

BURDON DW, 1981, MED LAB SCI, V38, P253

[2] CP-45,899, A BETA-LACTAMASE INHIBITOR THAT EXTENDS ANTIBACTERIAL SPECTRUM OF BETA-LACTAMS - INITIAL BACTERIOLOGICAL CHARACTERIZATION [J].

ENGLISH, AR ;

RETSEMA, JA ;

GIRARD, AE ;

LYNCH, JE ;

BARTH, WE .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1978, 14 (03) :414-419

[3] CLINICAL PHARMACOLOGY OF AMPICILLIN AND HETACILLIN [J].

KIRBY, WMM ;

KIND, AC .

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1967, 145 (A2) :291-&

[4] CLAVULANIC ACID AND CP-45,899 - A COMPARISON OF THEIR INVITRO ACTIVITY IN COMBINATION WITH PENICILLINS [J].

WISE, R ;

ANDREWS, JM ;

BEDFORD, KA .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1980, 6 (02) :197-206

[5] AFTER PRO-DRUGS - MUTUAL PRO-DRUGS [J].

WISE, R .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1981, 7 (05) :503-504